For the pharmaceutical industry and the broader scientific community, creating and producing effective COVID-19 vaccines has been a challenge and opportunity of a lifetime — a chance to help save humanity from an urgent global crisis.

The Coronavirus pandemic created new risks for patients and care givers alike. Significant new safety practices and costs will be standard for years to come—perhaps forever, as we seek to eliminate the spread of the Coronavirus as well as any future viral threats.

Chronic lower back pain (CLBP) is the second leading cause of disability worldwide. The prevalence of CLBP in adults has grown significantly over the last ten years.

Cannabis culture is not new and is not restricted to recreational purposes. The use of cannabis, a.k.a. marijuana, for medicinal purposes such as joint pain, muscle spasms, gout, spinal cord injury, and insomnia, dates back to as early as 5000 BC.

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and accounted for around 85% of all lung cancers in the United States.

The total U.S. weight loss market hit a new peak in 2019, growing to $78 billion. However, that growth came to a halt when the Coronavirus hit in March, shutting the doors of weight loss centers, doctors’ offices, clinics, and other businesses for 8-10 weeks. As a result, the value of the market is forecast to decline by 9% this year.

It is a major cause for concern that there is no proper vaccination and official treatment available that can help mitigate the coronavirus pandemic so far. Thus, it is imperative for researchers and scientists to explore different approaches and devise ways to counter this global health crisis.

The novel coronavirus, SARS-CoV-2, also known as COVID-19, has now become a pandemic, leaving all healthcare institutions and government officials baffled, and researchers and scientists on high alert.